Indexed with PubMed and Science Citation Index (E) 
Users online: 16189 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (1,147 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Figures
   Article Tables

 Article Access Statistics
    PDF Downloaded145    
    Comments [Add]    

Recommend this journal


Year : 2010  |  Volume : 76  |  Issue : 1  |  Page : 71-73

Naevoid basal cell carcinoma syndrome

1 Department of Dermatology, Isfahan University School of Medical Sciences, Alzahra Hospital, Iran
2 Department of Skin Diseases and Leishmaniasis Research Center, Isfahan University School of Medical Sciences, Alzahra Hospital, Iran

Date of Web Publication6-Jan-2010

Correspondence Address:
Amir Hossein Siadat
Sedigheh Tahereh Research Center, Khoram Street, Isfahan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0378-6323.58690

Rights and Permissions

How to cite this article:
Shahmoradi Z, Andalib F, Siadat AH. Naevoid basal cell carcinoma syndrome. Indian J Dermatol Venereol Leprol 2010;76:71-3

How to cite this URL:
Shahmoradi Z, Andalib F, Siadat AH. Naevoid basal cell carcinoma syndrome. Indian J Dermatol Venereol Leprol [serial online] 2010 [cited 2020 Nov 30];76:71-3. Available from:


Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms. The syndrome, delineated by Gorlin and Goltz in 1960, was first reported in 1894 and has been given several different names including Gorlin syndrome, Gorlin-Goltz syndrome, Nevoid basal cell carcinoma syndrome (NBCCS), multiple nevoid basal-cell carcinoma syndrome (MNBCCS), multiple basal-cell carcinoma syndrome, basal cell nevus syndrome (BCNS), multiple basalioma syndrome, fifth phacomatosis, jaw cysts-basal cell tumors-skeletal anomalies syndrome, odontogenic keratocytosis-skeletal anomalies syndrome, multiple nevoid basal-cell epithelioma-jaw cysts-bifid rib syndrome, hereditary cutaneomandibular polyoncosis and finally epitheliomatose multiple generalisee. [1]

The estimated prevalence varies from 1/57,000 to 1/256,000, with a male-to-female ratio of 1:1. [2] Main clinical manifestations include multiple basal cell carcinomas (BCCs), odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles, skeletal abnormalities, intracranial ectopic calcifications, and facial dysmorphism (macrocephaly, cleft lip/palate and severe eye anomalies).

In the current case series, we present three confirmed cases of NBCCS with review of their manifestations [Table 1].

The diagnostic criteria for NBCC was put forth by Evans and Colleagues and modified by Kimoni in 1997. According to him, diagnosis of Gorlin syndrome can be established when two major or one major and two minor criteria as described below, are present.

Major criteria include more than two basal cell carcinoma or one basal carcinoma at younger than 30 years of age or more than10 basal cell nevi, any odontogenic keratocyst (proven on histology) or polyostotic bone cyst, three or more palmar or plantar pits, ectopic calcification lamellar or early at younger than 20 years of age, falx cerebri calcification and positive family history of nevoid basal cell carcinoma.

Minor criteria include congenital skeletal anomaly, bifid, fused, splayed, missing or bified rib, wedged or fused vertebra, occipital-frontal circumference more than 97 percentile with frontal bossing, cardiac or ovarian fibroma, medulloblastoma, lymphomesentric cysts, and congenital malformations such as cleft lip or palate, polydactylism or eye anomaly (cataract, coloboma, microphthalmus). [3],[4]

In our first case, two major (multiple BCCs at younger than 30 years old, and palmar pits) and one minor (medulloblastoma) criteria were met, which were indicative of Gorlin syndrome. The second case had two major criteria (multiple BCCs before 30 years and odontogenic keratocyst), which confirmed Gorlin syndrome. The third case had one major criterion (multiple BCCs) and two minor criteria (congenital skeletal anomaly and frontal bossing) which confirmed Gorlin syndrome.

Early diagnosis and treatment is important to prevent long term squeals of this syndrome that include malignancy and oromaxillofacial deformation and destruction. Aggressive BCC causes death of the patient as a result of tumor invasion to the brain or other vital structures and medulloblastoma associated with the syndrome causes death during infancy. [5] Because of recurrence of odontogenic keratocysts, varying degrees of jaw deformity may result from operations for multiple cysts.[Figure 1],[Figure 2],[Figure 3],[Figure 4]

  References Top

1.Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008:32-3.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Lo Muzio L, Nocini PF, Savoia A, Consolo U, Procaccini M, Zelante L, et al. Nevoid basal cell carcinoma syndrome: Clinical findings in 37 Italian affected individuals. Clin Genet 1999;55:34-40.  Back to cited text no. 2      
3.Manfredi M, Vescovi P, Bonanini M, Porter S. Nevoid basal cell carcinoma syndrome: A review of literature. Int J Oral Maxillofac Surg 2004;33:117-24.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Muzio LL, Nocini P, Bucci, P, Pannone G, Procaccini M. Early diagnosis of Nevoid basal cell carcinoma syndrome. Am Dent Assoc 1999;130:669-74.  Back to cited text no. 4      
5.Gorlin RJ. Nevoid Basal cell carcinoma syndrome. Medicine 1977;66:97-113.  Back to cited text no. 5      


  [Figure 1], [Figure 2], [Figure 3], [Figure 4]

  [Table 1]


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow